Last update 08 May 2025

PSMA x STEAP1 x Tubulin

Basic Info

Related Targets
PSMASTEAP1Tubulin

Related

1
Drugs associated with PSMA x STEAP1 x Tubulin
DXC-008
Target
PSMA x STEAP1 x Tubulin
Mechanism
PSMA inhibitors [+2]
Active Org.
Hangzhou DAC Biotechnology Co., Ltd.Hangzhou DAC Biotechnology Co., Ltd.
Originator Org.
Hangzhou DAC Biotechnology Co., Ltd.Hangzhou DAC Biotechnology Co., Ltd.
Active Indication
Ewing Sarcoma [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with PSMA x STEAP1 x Tubulin
NCT06926283
/ Not yet recruitingPhase 1
A Phase I, Open-Label, Multicenter, First-in-Human, Dose Escalation and Expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profiles and Preliminary Efficacy of DXC008 in Patients With Prostate Cancer and Other Solid Tumors (Such as Ewing Sarcoma)
100 Clinical Results associated with PSMA x STEAP1 x Tubulin
Login to view more data
100 Translational Medicine associated with PSMA x STEAP1 x Tubulin
Login to view more data
0 Patents (Medical) associated with PSMA x STEAP1 x Tubulin
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free